Statements (9)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:developedBy |
gptkb:Anthera_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
blisibimod
|
| gptkbp:intendedUse |
gptkb:systemic_lupus_erythematosus
|
| gptkbp:mechanismOfAction |
BAFF inhibitor
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:status |
investigational drug
|
| gptkbp:bfsParent |
gptkb:Anthera_Pharmaceuticals
|
| gptkbp:bfsLayer |
7
|